Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CONMED Corp Director's Dealing 2024

Mar 11, 2024

31971_dirs_2024-03-11_3eda46f2-0ee1-429c-b1e0-0e80e47d6e89.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CONMED Corp (CNMD)
CIK: 0000816956
Period of Report: 2024-03-08

Reporting Person: Cohen Heather L (EVP & Chief HR & Legal Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2024-03-08 Common Stock M 27500 $59.96 Acquired 56870 Direct
2024-03-08 Common Stock F 22258 $85.425 Disposed 34612 Direct
2024-03-08 Common Stock M 25000 $78.76 Acquired 59612 Direct
2024-03-08 Common Stock F 23847 $85.225 Disposed 35765 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2024-03-08 Options To Purchase Common Stock $59.96 M 27500 Disposed 2028-03-01 Common Stock (27500) Direct
2024-03-08 Options To Purchase Common Stock $78.76 M 25000 Disposed 2029-03-01 Common Stock (25000) Direct

Footnotes

F1: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.

F2: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period